CLS Holdings USA (XCNQ:CLSH) YoY EBITDA Growth : -671.43% (As of Feb. 2024)

View and export this data going back to 2019. Start your Free Trial

What is CLS Holdings USA YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. CLS Holdings USA's YoY EBITDA Growth for the quarter that ended in Feb. 2024 was -671.43%.

CLS Holdings USA's EBITDA per Share for the three months ended in Feb. 2024 was C$-0.04.

CLS Holdings USA YoY EBITDA Growth Historical Data

The historical data trend for CLS Holdings USA's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CLS Holdings USA YoY EBITDA Growth Chart

CLS Holdings USA Annual Data

Trend

May14

May15

May16

May17

May18

May19

May20

May21

May22

May23

YoY EBITDA Growth

Get a 7-Day Free Trial

-87.77

-0.67

71.23

129.11

-299.01

CLS Holdings USA Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
YoY EBITDA Growth	Get a 7-Day Free Trial															75.00	-288.89	50.00	96.43	-671.43

CLS Holdings USA YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

CLS Holdings USA's YoY EBITDA Growth for the fiscal year that ended in May. 2023 is calculated as:

	YoY EBITDA Growth (A: May. 2023 )
=	(EBITDA per Share (A: May. 2023 )	-	EBITDA per Share (A: May. 2022 ))	/	\| EBITDA per Share (A: May. 2022 ) \|
=	(-0.201	-	0.101)	/	\| 0.101 \|
=	-299.01 %

CLS Holdings USA's YoY EBITDA Growth for the quarter that ended in Feb. 2024 is calculated as:

	YoY EBITDA Growth (Q: Feb. 2024 )
=	(EBITDA per Share (Q: Feb. 2024 )	-	EBITDA per Share (Q: Feb. 2023 ))	/	\| EBITDA per Share (Q: Feb. 2023 )) \|
=	(-0.04	-	0.007)	/	\| 0.007 \|
=	-671.43 %

CLS Holdings USA YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of CLS Holdings USA's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

CLS Holdings USA (XCNQ:CLSH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CLS Holdings USA Inc (XCNQ:CLSH) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

CLSH:USA

Address

1800 Industrial Road, Suite 100, Las Vegas, NV, USA, 89102

Website

https://www.clsholdingsinc.com

CLS Holdings USA Inc is a diversified cannabis company that acts as an integrated cannabis producer and retailer through its Oasis Cannabis subsidiaries in Nevada and plans to expand to other states. CLS stands for Cannabis Life Sciences in recognition of the company's patented proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency. The company's business model includes licensing operations, processing operations, processing facilities, sale of products, brand creation and consulting services. The company generates the majority of its revenues and corresponding accounts receivable from the sale of cannabis, and cannabis related products.